Target intelligence / Profile preview

Mitochondrial membrane phospholipids

Molecular classification
Lipid, Phospholipid
01

Overview

Mitochondrial membrane phospholipids are essential structural and functional lipids, primarily located in the inner mitochondrial membrane (IMM), where they facilitate cellular energy production and maintain organelle integrity (Mejia & Hatch, 2016). The most prominent member, cardiolipin, is unique for its dimeric structure and is vital for the stability of electron transport chain supercomplexes and the formation of cristae (Claypool & Koehler, 2012). Dysregulation of these phospholipids, particularly through oxidative damage or genetic defects in remodeling enzymes like tafazzin, is a hallmark of Barth syndrome and contributes to the progression of heart failure and neurodegenerative diseases (Chavez et al., 2020). Therapeutic agents such as elamipretide (SS-31) target these phospholipids by binding to cardiolipin, thereby preventing its peroxidation and stabilizing the IMM to enhance ATP synthesis and reduce reactive oxygen species (Szeto, 2014). Consequently, these lipids represent a critical therapeutic target for restoring mitochondrial bioenergetics and preventing cell death in various metabolic and age-related pathologies.

Other names
Mitochondrial lipidsInner mitochondrial membrane phospholipidsCardiolipinPhosphatidylethanolaminePhosphatidylcholinePhosphatidylinositol
02

Mechanism of action

Stabilization of cardiolipin-protein complexes, prevention of cardiolipin peroxidation, and maintenance of mitochondrial membrane curvature and cristae structure (Szeto, 2014; Mejia & Hatch, 2016).

03

Biological functions

ATP synthesisMitochondrial cristae organizationApoptosis regulationProtein importMembrane fusion and fission
04

Disease associations

Barth syndromeHeart failureIschemia-reperfusion injuryNeurodegenerative diseaseMetabolic syndrome
05

Safety considerations

Potential for non-specific membrane disruptionSystemic lipid metabolism interferenceLimited long-term safety data for mitochondrial-targeted peptides
06

Interacting drugs

Elamipretide

2 more in the full profile.

07

Biomarkers

Monolyso-cardiolipin to cardiolipin ratioCardiolipin contentMitochondrial oxygen consumption rate

Beyond the preview

Go deeper on Mitochondrial membrane phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial membrane phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call